Factor V Leiden Heterozygous Risks in Pregnancy
Factor V Leiden Heterozygous Risks in Pregnancy If you are a woman who is Factor V Leiden Heterozygous and planning to start a family, it is important to understand the unique risks and considerations associated with this genetic condition during pregnancy. Factor V Leiden Heterozygous refers to a specific genetic mutation that affects blood clotting, increasing the chances of developing potentially serious complications. In this article, we will explore the genetic factors behind Factor V Leiden and delve into the potential pregnancy complications that may arise.
Factor V Leiden is the most common inherited form of thrombophilia, a condition that leads to an increased risk of blood clots. This mutation affects one of the clotting factors in the blood, making it more prone to clotting when there is no real need for it. This can lead to the formation of blood clots in veins, especially during pregnancy, where hormonal changes and increased blood volume further contribute to the risk.
When a woman is heterozygous for Factor V Leiden, it means she carries one normal copy of the gene and one mutant copy. This genetic makeup increases the risk of developing blood clots, particularly deep vein thrombosis (DVT) and pulmonary embolism (PE), during pregnancy. These blood clots can potentially be life-threatening for both the mother and the baby.
Get Free Consultation
ACIBADEM Health Point: The Future of Healthcare
We believe that everyone deserves access to quality healthcare, which is why we have established multiple branches in strategic locations. Whether you're in need of routine check-ups, specialized treatments, or emergency care, ACIBADEM Health Point is here for you.During pregnancy, Factor V Leiden Heterozygous women face a higher risk of complications such as preeclampsia, which is characterized by high blood pressure and damage to organs such as the liver and kidneys. They are also at an increased risk of miscarriage, placental abruption (where the placenta separates from the uterus), and stillbirth. Close monitoring and specialized care are essential to ensure a safe and healthy pregnancy for both the mother and the baby.
If you have been diagnosed with Factor V Leiden Heterozygous, it is crucial to work closely with your healthcare provider to manage and mitigate the risks associated with this condition during pregnancy. Regular monitoring, anticoagulant therapy, lifestyle modifications, and high-risk obstetric care are some of the strategies commonly employed to reduce the likelihood of complications.
In the following sections, we will delve deeper into understanding Factor V Leiden Heterozygous, its implications during pregnancy, the increased risk of blood clots, specific pregnancy complications, testing and diagnosis, pregnancy management, preconception counseling and planning, genetic counseling and family planning, as well as the importance of high-risk obstetric care and antenatal monitoring. We will also touch upon delivery and postpartum considerations and discuss the outlook for individuals with Factor V Leiden Heterozygous after pregnancy.
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.Understanding Factor V Leiden Heterozygous
Factor V Leiden Heterozygous is a genetic condition that affects blood clotting in individuals. It is named after Leiden, the Dutch city where it was discovered. This condition is characterized by a mutation in the F5 gene, specifically in the Factor V gene. The genetic mutation leads to an increased risk of developing blood clots, which can have implications for individuals, especially during pregnancy.
The F5 gene is responsible for producing a protein called Factor V, which plays a crucial role in the clotting process. When a blood vessel is injured, Factor V helps initiate a series of reactions that result in the formation of a blood clot to prevent excessive bleeding. However, in individuals with Factor V Leiden Heterozygous, the mutation causes an alteration in the structure of the Factor V protein, making it more resistant to degradation.
As a result, individuals with Factor V Leiden Heterozygous have an increased risk of forming abnormal blood clots, particularly in deep veins (deep vein thrombosis) and in the lungs (pulmonary embolism). These blood clots can be dangerous and potentially life-threatening. During pregnancy, the risk of blood clots increases due to hormonal changes and the natural clotting factors that occur in the body as a protective mechanism during childbirth.
Being heterozygous for Factor V Leiden means that an individual carries one mutated gene and one normal gene. Heterozygosity for this condition increases the risk of blood clots compared to individuals who do not carry the mutation at all. However, the risk is lower compared to individuals who are homozygous for the Factor V Leiden mutation, meaning they carry two mutated genes.
When it comes to pregnancy, Factor V Leiden Heterozygous individuals face unique challenges. The combination of hormonal changes and increased blood clotting factors during pregnancy can further amplify the risk of blood clots. The presence of the Factor V Leiden mutation adds an additional layer of risk, increasing the chances of developing complications such as deep vein thrombosis, pulmonary embolism, miscarriage, preeclampsia, and placental abruption.
It is important for individuals with Factor V Leiden Heterozygous to be aware of their condition and work closely with their healthcare provider to manage any potential risks during pregnancy. Close monitoring, appropriate preventive measures, and specialized obstetric care can significantly reduce the chances of complications and ensure a safe pregnancy for both the mother and the baby.
Increased Risk of Blood Clots in Pregnancy
Factor V Leiden Heterozygous individuals face an increased risk of blood clots during pregnancy. This is due to a condition called Factor V Leiden thrombophilia, which affects the blood’s ability to clot properly. When combined with the changes that occur in the body during pregnancy, this can further elevate the risk of blood clots.
During pregnancy, the body naturally undergoes changes to support the growth and development of the baby. These changes include an increase in estrogen and progesterone levels, as well as alterations in blood composition and flow. While these changes are necessary for a healthy pregnancy, they can also contribute to an increased risk of blood clot formation.
Factor V Leiden Heterozygous individuals have a genetic mutation that affects the production of a protein called Factor V. This protein plays a crucial role in the blood clotting process. In individuals with Factor V Leiden thrombophilia, there is an increased risk of developing abnormal blood clots.
These blood clots can potentially cause serious complications for both the mother and the baby. In some cases, they can lead to deep vein thrombosis (DVT), pulmonary embolism (PE), or stroke. These conditions can be life-threatening if not promptly diagnosed and treated.
It is important for pregnant individuals with Factor V Leiden Heterozygous to be aware of this increased risk and to work closely with their healthcare provider to minimize the chances of blood clot formation. Appropriate preventive measures, such as the use of blood-thinning medications, may be recommended to manage the risk. Regular monitoring and close observation throughout pregnancy can help ensure early detection and timely intervention if necessary.
| Complications | Risk |
|---|---|
| Deep Vein Thrombosis (DVT) | Increased |
| Pulmonary Embolism (PE) | Increased |
| Stroke | Increased |
| Clotting in the Placenta | Increased |
| Restriction of Blood Flow to the Baby | Increased |
Pregnancy Complications Associated with Factor V Leiden Heterozygous
Factor V Leiden Heterozygous individuals face a heightened risk of experiencing pregnancy complications. This genetic condition, characterized by an altered form of Factor V protein, can contribute to various gestational challenges, potentially impacting both the mother and the baby.
Miscarriage:
Factor V Leiden Heterozygous and pregnancy complications may include an increased risk of miscarriage. Research suggests that women with this condition are more susceptible to miscarriages, particularly in their first trimester. It is essential for healthcare professionals to closely monitor these pregnancies to mitigate such risks and offer appropriate support.
Preeclampsia:
Another factor V leiden and pregnancy complication that individuals with Factor V Leiden Heterozygous may face is preeclampsia. Preeclampsia is a condition characterized by high blood pressure and damage to organs, such as the liver or kidneys. Studies have indicated a correlation between Factor V Leiden Heterozygous and increased preeclampsia risk, necessitating careful monitoring and management.
Placental Abruption:
Factor V Leiden Heterozygous has also been associated with an elevated risk of placental abruption, which occurs when the placenta separates from the uterine wall before delivery. This complication can cause heavy bleeding and potentially endanger both the mother and the baby. Close surveillance and prompt medical intervention are crucial in mitigating the impact of placental abruption.
Other potential complications that may occur in pregnancies involving Factor V Leiden Heterozygous individuals include preterm birth, intrauterine growth restriction, and deep vein thrombosis. It is important for expectant mothers and their healthcare providers to be vigilant, closely monitoring for any signs of these complications throughout the pregnancy.
| Complication | Description |
|---|---|
| Miscarriage | Increased risk, particularly in the first trimester. |
| Preeclampsia | Elevated risk of high blood pressure and organ damage. |
| Placental Abruption | Higher likelihood of separation of placenta from the uterine wall. |
| Preterm Birth | Increased risk of giving birth before the full term. |
| Intrauterine Growth Restriction | Potential restriction of fetal growth in the uterus. |
| Deep Vein Thrombosis | Greater susceptibility to blood clots in deep veins. |
Testing and Diagnosis During Pregnancy
Testing and diagnosing Factor V Leiden Heterozygous during pregnancy is crucial to ensure the well-being of both the mother and the baby. By identifying this genetic condition early on, healthcare professionals can implement appropriate management strategies and interventions to mitigate potential risks.
There are several testing methods available to detect Factor V Leiden Heterozygous during pregnancy:
- Genetic testing: This involves analyzing a blood sample to identify the presence of the Factor V Leiden mutation. Genetic testing is highly accurate and reliable in diagnosing the condition. It is usually recommended for individuals with a family history of the mutation or those who have experienced blood clotting events in the past.
- Thrombophilia screening: This is a comprehensive blood test that evaluates various clotting factors, including Factor V Leiden. It is often performed as part of routine prenatal care to assess the mother’s risk of developing blood clots during pregnancy.
- Ultrasound: In some cases, an ultrasound may be used to detect blood clots or other complications associated with Factor V Leiden Heterozygous. This non-invasive imaging technique can provide valuable information about the health of both the mother and the baby.
The timing of testing and diagnosis during pregnancy is crucial. It is typically recommended to undergo testing early in the pregnancy to allow for appropriate management and intervention. However, in cases where there is a high suspicion of Factor V Leiden Heterozygous or a family history of the condition, testing may be performed even before conception or during preconception counseling.
By promptly diagnosing Factor V Leiden Heterozygous during pregnancy, healthcare professionals can take the necessary precautions to minimize the risk of blood clots and other associated complications. Early intervention can significantly improve outcomes for both the mother and the baby.
| Testing Method | Advantages | Disadvantages |
|---|---|---|
| Genetic Testing | Precise and accurate diagnosis | May not be covered by insurance, requires blood sample |
| Thrombophilia Screening | Comprehensive evaluation of clotting factors | May not specifically identify Factor V Leiden |
| Ultrasound | Non-invasive imaging, provides visual information | May not detect all complications or blood clots |
Pregnancy Management for Factor V Leiden Heterozygous Individuals
Managing a pregnancy with Factor V Leiden Heterozygous involves a comprehensive approach that focuses on minimizing the risks associated with blood clotting. With proper pregnancy management, individuals with this genetic condition can have a safe and healthy pregnancy.
Anticoagulant Therapy
To reduce the risk of blood clots, anticoagulant therapy is often recommended for Factor V Leiden Heterozygous individuals during pregnancy. This may involve the use of medications such as low molecular weight heparin or aspirin, which can help prevent the formation of blood clots.
Lifestyle Modifications
In addition to medication, lifestyle modifications can play a crucial role in managing pregnancy for Factor V Leiden Heterozygous individuals. Maintaining a healthy weight, staying active with regular exercise under medical supervision, and avoiding prolonged periods of immobility can help reduce the risk of blood clots.
Close Monitoring
Close monitoring throughout the pregnancy is essential for identifying any potential complications. Regular check-ups with healthcare providers, including obstetricians and hematologists, allow for early detection of any issues and prompt intervention if necessary.
Increased Awareness
Frequent patient education and awareness about the signs and symptoms of blood clots during pregnancy are also crucial. Empowering individuals with knowledge enables them to recognize potential warning signs and seek medical attention promptly, minimizing the risk of complications.
Collaborative Care
Managing a pregnancy with Factor V Leiden Heterozygous often requires a multidisciplinary approach. A team of healthcare professionals, including obstetricians, hematologists, and genetic counselors, collaborate to provide comprehensive care and support throughout the pregnancy journey.
Recommended Pregnancy Management for Factor V Leiden Heterozygous Individuals
| Management Strategy | Description |
|---|---|
| Anticoagulant Therapy | Prescribing medications such as low molecular weight heparin or aspirin to reduce blood clotting risk |
| Lifestyle Modifications | Encouraging healthy weight, regular exercise, and avoiding prolonged immobility |
| Close Monitoring | Regular check-ups with healthcare providers to identify and address any potential complications |
| Increased Awareness | Providing education about the signs and symptoms of blood clots to promote early detection |
| Collaborative Care | A multidisciplinary approach involving obstetricians, hematologists, and genetic counselors |
By implementing these pregnancy management strategies, individuals with Factor V Leiden Heterozygous can navigate their pregnancy journey with confidence, knowing that they are taking proactive steps to mitigate potential risks and optimize maternal and fetal health.
Preconception Counseling and Planning
Preconception counseling and planning are crucial for individuals with Factor V Leiden Heterozygous who are considering pregnancy. By seeking professional guidance and preparing in advance, you can better understand and manage the potential risks associated with this genetic condition. Acibadem Healthcare Group, a renowned institution specializing in high-risk obstetric care, offers comprehensive preconception counseling services to support you in your journey.
During preconception counseling, the experts at Acibadem Healthcare Group will evaluate your medical history, perform genetic testing if necessary, and assess your individual risk factors. They will provide you with personalized recommendations to minimize complications and optimize your chances of a healthy pregnancy.
What to expect during preconception counseling:
- Evaluation of personal and family medical history
- Genetic testing and counseling, if needed
- Discussion of your specific risk factors
- Recommendations on lifestyle modifications
- Education on potential pregnancy complications
By taking proactive steps before conception, you can ensure that you receive the necessary care and support throughout your pregnancy journey. Acibadem Healthcare Group’s experienced team of specialists will guide you every step of the way, helping you make informed decisions and providing the highest quality of care.
| Benefits of preconception counseling and planning: | Expertise of Acibadem Healthcare Group: |
|---|---|
|
|
Note: The information provided here is for informational purposes only and should not replace professional medical advice. Consult with your healthcare provider for personalized guidance.
Genetic Counseling and Family Planning
Genetic counseling plays a crucial role in assisting individuals with Factor V Leiden Heterozygous in making informed decisions about family planning. By understanding the genetic implications and potential risks associated with this condition, individuals can take proactive steps to ensure the health of future generations. Genetic counseling offers a supportive and educational environment where individuals can explore various aspects of family planning while considering their unique circumstances.
One of the primary concerns for individuals with Factor V Leiden Heterozygous is the risk of passing on the condition to their children. Genetic counselors provide detailed information about the genetics of Factor V Leiden and the likelihood of inheritance. They explain that being heterozygous increases the risk of a child inheriting the condition but does not guarantee it. The Factor V Leiden genetics are complex, and individuals may carry other genetic variations contributing to the overall risk.
During genetic counseling sessions, individuals can discuss reproductive options and explore assisted reproductive technologies, such as preimplantation genetic diagnosis (PGD) or in vitro fertilization (IVF), which allow for genetic testing of embryos before implantation. These advanced techniques can help reduce the risk of transmitting Factor V Leiden, providing individuals and couples with greater control over their family planning journey.
Benefits of Genetic Counseling for Family Planning
Genetic counseling offers several benefits in the context of family planning for individuals with Factor V Leiden Heterozygous:
- Clear Understanding: Genetic counselors can break down complex genetic concepts and provide individuals with a clear understanding of the inheritance patterns and potential risks associated with Factor V Leiden.
- Personalized Risk Assessment: Genetic counselors can perform personalized risk assessments based on an individual’s unique genetic and medical history, helping them make informed decisions about family planning.
- Exploration of Reproductive Options: Genetic counselors can discuss various reproductive options, including prenatal testing or assisted reproductive technologies, allowing individuals to make empowered choices that align with their personal goals and values.
- Psychological Support: Dealing with the potential risks and decision-making associated with family planning can be emotionally challenging. Genetic counselors provide a supportive and empathetic environment, offering emotional support throughout the counseling process.
Overall, genetic counseling serves as a valuable resource for individuals with Factor V Leiden Heterozygous who are considering family planning. By providing in-depth information, guidance, and support, genetic counselors help individuals navigate the complexities of genetic risks and make informed decisions regarding their reproductive journey.
| Advantages of Genetic Counseling for Family Planning | Examples |
|---|---|
| Clear Understanding | Break down complex genetics and inheritance patterns. |
| Personalized Risk Assessment | Assess individual genetic and medical history for tailored risk evaluation. |
| Exploration of Reproductive Options | Discuss prenatal testing and assisted reproductive technologies. |
| Psychological Support | Offer emotional support throughout the counseling process. |
High-Risk Obstetric Care
For individuals with Factor V Leiden Heterozygous, receiving specialized high-risk obstetric care during pregnancy is essential. This level of care ensures that both the mother and the baby are closely monitored and any potential complications are addressed promptly.
The Acibadem Healthcare Group offers comprehensive obstetric care for women with Factor V Leiden Heterozygous. With a team of experienced obstetricians and state-of-the-art facilities, Acibadem healthcare group provides personalized care and guidance throughout the pregnancy journey.
Expert Care for a Safe Pregnancy
At Acibadem, we understand the unique challenges faced by individuals with Factor V Leiden Heterozygous. Our highly skilled team closely monitors the pregnancy, regularly assessing the mother’s health and the baby’s development to detect any potential risks early on. This proactive approach helps in preventing complications and ensuring a safe pregnancy and delivery.
Throughout the pregnancy, individuals with Factor V Leiden Heterozygous may require specialized interventions, such as anticoagulant therapy, to reduce the risk of blood clots. Our team of specialists at Acibadem Healthcare Group has extensive experience in managing high-risk pregnancies, including those with thrombophilia, like Factor V Leiden Heterozygous.
State-of-the-Art Facilities
Acibadem Healthcare Group offers state-of-the-art facilities equipped with the latest technology to provide the highest level of care for individuals with Factor V Leiden Heterozygous. Our hospitals are equipped with advanced diagnostic tools and our team utilizes cutting-edge techniques for obstetric monitoring and interventions, ensuring the best outcomes for both mother and baby.
Collaborative Approach to Care
At Acibadem, we believe in a collaborative approach to care. Our team of experts works closely with genetic counselors and other healthcare professionals to provide comprehensive care that considers all aspects of the patient’s health and well-being during pregnancy. This interdisciplinary approach ensures that individuals with Factor V Leiden Heterozygous receive the highest quality care, personalized to their specific needs.
With the expertise of Acibadem Healthcare Group, individuals with Factor V Leiden Heterozygous can have peace of mind knowing that they are in safe hands throughout their pregnancy journey.
Antenatal Monitoring and Close Surveillance
Antenatal monitoring and close surveillance play a crucial role in managing pregnancies involving Factor V Leiden Heterozygous individuals. Regular check-ups, ultrasounds, and blood tests are essential tools in ensuring the well-being of both the mother and the baby.
During these routine check-ups, healthcare professionals closely monitor the mother’s blood clotting levels and assess any potential risks or complications. They also keep a close eye on the baby’s growth and development, ensuring that they are thriving in the womb.
Ultrasounds, a non-invasive imaging technique, are used to monitor the baby’s growth, assess their organs and overall well-being, and detect any signs of abnormalities or potential complications.
Blood tests are performed to measure specific markers that indicate the risk of blood clots and other complications. These tests help healthcare providers adjust management strategies accordingly, ensuring optimal care and minimizing potential risks.
In addition to these monitoring procedures, pregnant individuals with Factor V Leiden Heterozygous may need to take anticoagulant medications to prevent blood clot formation. Close surveillance is especially important in these cases to ensure the medication’s efficacy and prevent any adverse effects.
Overall, antenatal monitoring and close surveillance are vital components of the pregnancy management plan for individuals with Factor V Leiden Heterozygous. By closely monitoring both the mother and the baby, healthcare professionals can identify potential risks early on and take necessary measures to prioritize their health and well-being.
| Benefits of Antenatal Monitoring and Close Surveillance | Risks of Inadequate Monitoring |
|---|---|
| Early detection of potential complications | Missed opportunities for timely intervention |
| Optimized management strategies | Increased risk of complications going unnoticed |
| Reduced risk of blood clots | Delayed diagnosis of fetal abnormalities |
| Improved overall maternal and fetal outcomes | Unmanaged risks leading to adverse pregnancy outcomes |
In conclusion, antenatal monitoring and close surveillance are essential for managing pregnancies involving Factor V Leiden Heterozygous individuals. Regular check-ups, ultrasounds, and blood tests enable healthcare professionals to closely monitor the well-being of the mother and baby, detect potential complications early, and implement the necessary management strategies to ensure a safe and healthy pregnancy.
Delivery and Postpartum Considerations
Individuals with Factor V Leiden Heterozygous face unique considerations during delivery and in the postpartum period. It is crucial to be aware of potential risks and take appropriate precautions to ensure a safe and healthy outcome for both the mother and the baby.
Risks and Precautions During Labor
Factor V Leiden Heterozygous individuals have an increased risk of developing blood clots, which can be further exacerbated during labor. The use of medical interventions such as labor induction or cesarean delivery may also increase the risk. It is essential for healthcare providers to closely monitor these individuals during labor and take necessary precautions to minimize the risk of blood clots.
In some cases, the use of anticoagulant medication may be considered to prevent blood clot formation. However, the decision to use anticoagulants should be made on a case-by-case basis, weighing the potential benefits against the possible risks.
Postpartum Monitoring and Care
After delivery, individuals with Factor V Leiden Heterozygous should receive postpartum monitoring and care to ensure early detection of any complications. The risk of blood clots persists in the postpartum period, particularly in the first few weeks. Therefore, close observation and appropriate measures should be taken to prevent and manage any potential clotting events.
Healthcare providers may recommend the use of anticoagulant therapy during the postpartum period to reduce the risk of blood clots. Postpartum monitoring may involve regular blood tests, ultrasounds, and close follow-up appointments to assess the mother’s clotting status and overall well-being.
Support and Education
It is important for individuals with Factor V Leiden Heterozygous to receive comprehensive support and education regarding delivery and postpartum considerations. This may include guidance on self-care measures, signs and symptoms of potential complications, and when to seek immediate medical attention.
Support groups or counseling services may also be beneficial in helping individuals navigate the emotional challenges that can arise during this time. Connecting with other individuals who have had similar experiences can provide a supportive community and valuable insights.
Outlook and Future Perspectives
After pregnancy, individuals with Factor V Leiden Heterozygous can look forward to a hopeful outlook. While pregnancy itself may pose certain risks, the majority of women with this condition go on to have successful and healthy pregnancies. With proper medical management and close monitoring, the potential complications can be minimized or even prevented.
Looking ahead, advancements in medical research and technology continue to shed light on Factor V Leiden Heterozygous and its impact on pregnancy. Ongoing studies aim to further understand the genetic basis of this condition, identify additional risk factors, and develop more effective preventive measures.
Moreover, healthcare providers and specialists, such as those at Acibadem Healthcare Group, are at the forefront of providing comprehensive care to individuals with Factor V Leiden Heterozygous. Their expertise in high-risk obstetric care and genetic counseling ensures that patients receive personalized and evidence-based management throughout their pregnancy journey.
FAQ
What is Factor V Leiden Heterozygous?
Factor V Leiden Heterozygous is a genetic mutation that affects blood clotting. It is characterized by the presence of one copy of the mutated Factor V Leiden gene, which increases the risk of abnormal clot formation.
How does Factor V Leiden Heterozygous affect pregnancy?
Factor V Leiden Heterozygous can have implications during pregnancy as it increases the risk of blood clots. This can lead to complications such as miscarriage, preeclampsia, and placental abruption.
What are the risks associated with Factor V Leiden Heterozygous during pregnancy?
Individuals with Factor V Leiden Heterozygous have an increased risk of developing blood clots during pregnancy. These clots can obstruct blood flow to the placenta, potentially affecting the health of the baby. There is also an increased risk of complications such as deep vein thrombosis and pulmonary embolism for the mother.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now !*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of ACIBADEM Health Group.